#clinical trial — Friday, June 05, 2026 (2 items)
| 0 | ℹ |
Obinutuzumab or Tacrolimus in Primary Membranous Nephropathy.
(nejm.org)
|
New England Journal of Medicine 2026-06-05 | #clinical trial #immunotherapy #autoimmune #membranous nephropathy | |
| 0 | ℹ |
Oral small molecule GLP-1 receptor agonist aleniglipron in people with overweight or obesity: a randomized, double-blind, placebo-controlled phase 2b trial.
(nature.com)
|
Nature Medicine 2026-06-05 | #metabolism #clinical trial #pharmacotherapy #obesity |